Hormone Receptor-Negative Breast Carcinoma

Hormone Receptor-Negative Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 17%
Top sponsor: Antonio Giordano, MD
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06264921	A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors	terminated	Phase 1	23	NiKang Therapeutics, Inc.INDUSTRY	1	Sep 25, 2025	clinicaltrials

Data updated 23 days agoSource updated Sep 25, 2025source: clinicaltrials